Physician profile

Eric B Johnson

Physician Assistant · Ogden, UT

NPI 1841289600

$4,771.66

in general payments reported to CMS, 2019-2025

41 companies · $956 in 2025

The $956 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,806.28

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Amgen INC. $887.39 2022-2025 Evenity, Prolia, Otezla
Abbvie INC. $869.87 2021-2025
Lilly USA, LLC $477.25 2021-2025 Mounjaro, Zepbound, Jardiance
Pfizer INC. $305.79 2021-2025
Biohaven Pharmaceutical Holding Company Ltd. $255.10 2022
Astrazeneca Pharmaceuticals Lp $231.13 2021-2025 Breztri, Flumist Quadrivalent, Airsupra
Glaxosmithkline, LLC. $199.56 2022-2025 Trelegy Ellipta, Shingrix, Arexvy
Astellas Pharma US INC $167.29 2021-2025 Veozah
Amarin Pharma, INC. $125.79 2021-2022
Abbott Laboratories $95.38 2021-2024 Freestyle Libre 3
Boehringer Ingelheim Pharmaceuticals, INC. $89.12 2021-2023 Jardiance, Synjardy
Eisai INC. $78.69 2021
Supernus Pharmaceuticals, INC. $65.37 2021-2022
Dynavax Technologies Corporation $65.01 2023-2025 Heplisav-B
Merck Sharp & Dohme LLC $63.58 2021-2023 Gardasil 9, Vaxelis, Rotateq
Show all 41 companies
CompanyGeneral paymentsYearsTop products
Organon LLC $60.56 2022-2025 Nexplanon
Janssen Pharmaceuticals, INC $57.28 2022-2024 Spravato
Biohaven Pharmaceuticals, INC. $57.05 2021
Cranial Technologies, INC $56.03 2023-2024 Doc Band
Genentech USA, INC. $52.21 2021
Novo Nordisk INC $51.97 2024-2025
Salix Pharmaceuticals, A Division of Bausch Health US, LLC $46.22 2021-2024 Trulance, Xifaxan
Sanofi-Aventis U.S. LLC $45.65 2021-2025
Ironshore Pharmaceuticals INC. $44.31 2021
Nestle Healthcare Nutrition INC. $32.06 2021-2023
Sanofi Pasteur INC. $28.85 2022-2023
Viiv Healthcare Company $24.25 2025 Apretude
Baxter Healthcare $23.82 2023 Hillrom - Life 2000 Ventilation System
Krystal Biotech INC $22.79 2024 Vyjuvek
Treace Medical Concepts, INC. $22.23 2024
Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) $19.08 2025 Caplyta
Currax Pharmaceuticals LLC $17.73 2023 Contrave
Shield Therapeutics INC $17.49 2024
Bayer Healthcare Pharmaceuticals INC. $17.17 2023
Axsome Therapeutics, INC. $15.54 2024 Auvelity
Verity Pharmaceuticals INC. $14.50 2025 Tlando
Gilead Sciences, INC. $14.39 2025
Idorsia Pharmaceuticals US INC $14.18 2023 Quviviq
Boston Scientific Corporation $13.92 2023 Wavewriter Alpha Prime 16
Lucid Diagnostics INC. $13.83 2022
Teva Pharmaceuticals USA, INC. $12.23 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Eric B Johnson

$4,771.66

in general payments reported 2019-2025

Years
2021-2025
Top company
Amgen INC.
Context
The $956 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).

https://glasscript.com/doctor/10857370/eric-b-johnson

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.